Enhanced Games is set to launch on May 24, drawing widespread controversy ahead of its debut, according to multiple Australian outlets. The products have been described as “sci-fi” or futuristic, and public debate centers on the use and marketing of peptides. Critics and commentators have raised questions about whether significant private wealth is being gained from peptide-related sales, including concerns about billionaire involvement and potential profit motives. While the outlets characterize the launch as controversial, they do not provide detailed, outlet-specific evidence in the summaries provided here regarding the company’s revenue model, ownership structure, or regulatory status. All three sources referenced focus on the same timing for the release and the same core criticism: that peptides sold in connection with the Enhanced Games promotion may benefit wealthy investors. As the May 24 launch date approaches, the controversy remains focused on the ethics and financial incentives surrounding the peptide products rather than on any reported change to the launch schedule or confirmed findings by regulators.